Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
131 JPY | +4,80% | +10,08% | -13,25% |
Vakgebied
Aantal werknemers: 22
Verkoop per activiteit
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Formulation Development and Related Operations
100,0
%
| 59 | 100,0 % | 30 | 100,0 % | -50,35% |
Verkoop per regio
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
75,6
%
| - | - | 22 | 75,6 % | - |
Japan
24,4
%
| 59 | 100,0 % | 7 | 24,4 % | -87,87% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 79 | 15-01-02 | |
President | 53 | 01-08-03 | |
Ken Fujioka
ADM | Chief Administrative Officer | 56 | 01-11-18 |
Chief Tech/Sci/R&D Officer | 55 | 15-01-02 | |
Hiroshi Akitomo
BRD | Director/Board Member | 63 | 01-06-02 |
Keiko Yamasaki
BRD | Director/Board Member | 74 | 15-01-02 |
Masaru Fukui
AUD | Comptroller/Controller/Auditor | 75 | 01-09-08 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 79 | 15-01-02 | |
President | 53 | 01-08-03 | |
Keiko Yamasaki
BRD | Director/Board Member | 74 | 15-01-02 |
Hiroshi Akitomo
BRD | Director/Board Member | 63 | 01-06-02 |
Chief Tech/Sci/R&D Officer | 55 | 15-01-02 | |
Kunio Iwatani
BRD | Director/Board Member | 82 | 01-03-16 |
Ken Fujioka
ADM | Chief Administrative Officer | 56 | 01-11-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 42 945 100 | 38 981 198 ( 90,77 %) | 2 ( 0,000005 %) | 90,77 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-13,25% | 32,96 mln. | |
+9,85% | 74,45 mld. | |
+11,35% | 9,18 mld. | |
-12,85% | 5,02 mld. | |
+60,16% | 5,03 mld. | |
+1,60% | 3,82 mld. | |
-19,20% | 2,41 mld. | |
+18,65% | 2,39 mld. | |
+24,62% | 2,26 mld. | |
-27,46% | 2,27 mld. |
- Beurs
- Aandelen
- Koers 4586
- Onderneming MedRx Co., Ltd